|Bid||294.34 x 800|
|Ask||294.65 x 800|
|Day's Range||293.03 - 298.33|
|52 Week Range||220.90 - 302.05|
|Beta (5Y Monthly)||0.50|
|PE Ratio (TTM)||32.48|
|Earnings Date||Feb 19, 2020 - Feb 24, 2020|
|Forward Dividend & Yield||2.60 (0.88%)|
|1y Target Est||289.79|
Domino's Pizza remains one of Oppenheimer’s top picks into 2020 despite the stock's outperformance in the fourth quarter. Oppenheimer expects accelerating same-store sales in 2020, thanks to factors such as new menu products, marketing, and fewer year-over-year competitive headwinds.
Months after launching its first partnership with Kroger, California-based Nuro has another retail partnership in the works.
Domino's (DPZ) new GPS delivery tracking technology will boost delivery experience for customers and enable it to better manage in-store logistics.
Hemsley, who was appointed as Domino's non-executive chairman in March 2010, will leave the company on Dec. 29. Senior Independent Director Ian Bull will assume the role of an interim chairman. CEO David Wild announced his intention to retire in August after the company said earlier this year it was considering replacing its CEO and chairman in the wake of the Financial Reporting Council's revised corporate code that emphasized the need for boards to refresh themselves.
The 2010s was an era of dramatic growth for the stock market. Climbing out of the depths of the financial crisis, growth stocks soared as interest rates fell to rock-bottom levels. Investors also returned to the market as stock growth, and eventually jobs, made a comeback.On Jan. 1, 2010, the S&P 500 stood at 1,123.58. This year, it finally broke through the 3,000 level. It stands at around 3,120 as of the time of this writing. This represents an increase of almost 178% in the 2010s.However, some growth stocks saw increases far exceeding that level. As technological change and the creative destruction of capitalism both birthed and destroyed industries, some long-term investors saw massive returns. Some of these equities received a significant amount of coverage in the financial press. Others remain unknown to much of the investing public.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Energy Stocks That Are Still Worth Buying In 2020 Still, the changes brought about by these forces will likely bring new growth stocks for the 2020s. Hence, one cannot assume this growth should continue. However, by understanding the influences that grew the following equities, investors can help themselves to prepare for hopefully a new roaring '20s. Domino's Pizza (DPZ)Source: Ken Wolter / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $7.20 Approximate price today: $288 per share Gain in 2010s: 3,889%Seeing Domino's Pizza (NYSE:DPZ) stock at the top of the list might come as a surprise. The first Domino's opened in 1960. The pizza chain began offering the "30-minute guarantee" for pizza delivery in 1973. However, it dropped the 30-minute guarantee in 1993 following a lawsuit, and the pizza chain suffered well into the 2000s due to numerous challenges.However, in 2010, J. Patrick Doyle took over as CEO. Doyle acknowledged the issues facing Domino's and initiated a successful marketing campaign. He also adjusted to the times as a significant portion of the order process shifted to online platforms. DPZ stock soared as both customers and investors responded well to the changes.Still, as one of the top growth stocks, DPZ faces new challenges. Richard Allison took over as CEO in July 2018. Now delivery services such as Uber (NYSE:UBER) and Grubhub (NYSE:GRUB) enable deliveries for more of its competitors.The projected average earnings increase of 12.8% per year for the next five years appears solid. However, at a forward price-to-earnings ratio of around 27, that growth does not come cheap. Investors should watch carefully as DPZ stock faces a bright if somewhat uncertain future. Netflix (NFLX)Source: Riccosta / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $7.87 per share Approximate price today: $305 per share Gain in 2010s: 3,773%Seeing Netflix (NASDAQ:NFLX) on this growth stocks list does not come as a surprise. The company first pioneered the DVD mail-order and streaming industries. Both events forced the video store industry and companies such as Blockbuster Video and Hollywood Video to close their doors.This industry also had the effect of making much pricier cable-TV plans less desirable. Both trends helped NFLX stock to skyrocket.However, the 2020s may look much different for Netflix stock. The success of streaming has brought competition from many sectors. Of those, Disney (NYSE:DIS) has become the most notable threat. A formidable content library and a streaming service for sports could blunt further gains in NFLX stock for the foreseeable future. Netflix has also damaged its balance sheet by taking on massive debts to keep up in the content race. * 7 Entertainment Stocks to Buy to Escape Holiday Blues The forward P/E ratio of 55 has come down in recent years. Also, the market capitalization has now risen to almost $134 billion. However, analysts project the profit growth rate of an average of 42.2% per year over the next five years. While NFLX stock will likely see much slower growth in the 2020s, international expansion could still take it higher. MarketAxess Holdings (MKTX)Source: Shutterstock Split-adjusted closing price on Dec. 31, 2009: $12.48 per share Approximate price today: $370 per share Gain in 2010s: 2,864%The massive growth over the last ten years has failed to make MarketAxess (NASDAQ:MKTX) a household name among growth stocks. Perhaps this is because the New York-based international fintech company deals little with the general public. Instead, it enables institutional investors and broker-dealers to trade several types of fixed-income products.MKTX stock generates most of its income from commissions. It grew as investors showed an increasing interest in bonds during the 2010s.Despite the impressive 2,864% growth over the last ten years, I would hesitate to buy it now. Wall Street predicts earnings increases will average 15.7% per year over the next five years. However, 60.1 times forward earnings seems pricey for such a growth rate.Still, I recommend keeping MKTX stock on a watch list. At a market cap of around $14 billion, it could have room to grow long term. A hiccup in bonds or the overall market could interrupt its move higher. If the P/E ratio falls more in line with the growth rate, I think MarketAxess will again become a buy. DexCom (DXCM)Source: FOOTAGE VECTOR PHOTO / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $8.07 per share Approximate price today: $221 per share Gain in 2010s: 2,638%Like MarketAxess, the growth of DexCom (NASDAQ:DXCM) has also occurred without a significant amount of public attention. Based in San Diego, this company commercialized glucose monitoring. This has only grown in significance as the aging of the baby-boom population sparks a rise in cases of diabetes.Moreover, about 10,000 baby boomers age into Medicare every day. Analysts expect this trend to endure for most of the next decade. DXCM stock should rise along with it. From an investor standpoint, this and the population already on Medicare helps to make monitoring more affordable.The rise in DXCM stock has left it with a forward P/E of around 122. At such levels, investors should remain cautious. However, Wall Street also expects earnings increases expected to average 78% per year over the next five years. Hence, traders can easily see why DexCom stock attracts such a premium. * 7 Exciting Biotech Stocks to Buy Now Admittedly, we all want to see a cure for diabetes. If this occurs, it could devastate DXCM stock. However, as long as it remains a health issue covered by Medicare, DexCom should remain one of the top growth stocks. Exact Sciences (EXAS)Source: Shutterstock Split-adjusted closing price on Dec. 31, 2009: $3.39 per share Approximate price today: $86 per share Gain in 2010s: 2,430%Consumers may not know the company Exact Sciences (NASDAQ:EXAS) well. However, it has become one of the top growth stocks for a product the public knows better, Cologuard. Thanks to Cologuard, patients can diagnose colon cancer early. Cologuard can do this without an invasive and more expensive colonoscopy. This reduces medical costs and means more people can detect colon cancer before tumors spread to other parts of the body.The Food and Drug Administration approved Cologuard in 2014. Consequently, nearly all of the stock price growth occurred after 2015. Moreover, despite the benefits of Cologuard, analysts do not forecast a profit for EXAS stock until 2021. At a price-to-sales ratio of 17, it has become an expensive investment. However, with revenue nearly doubling every year, investors have shown willingness to pay such a multiple.The benefits of Exact Sciences' popular product do not need an explanation. As long as this patent remains in force, I see growth continuing for EXAS stock despite the massive increase in the second half of the 2010s. Abiomed (ABMD)Source: Pavel Kapysh / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $8.73 per share Approximate price today: $188 per share Gain in 2010s: 2,076%Abiomed (NASDAQ:ABMD) makes medical devices to help the pumping functions within the human heart. They have also developed artificial hearts.Admittedly, ABMD stock might have become the biggest of the growth stocks had this analysis occurred at a different time. The pace of growth began to accelerate in 2014. By October 2018, Abiomed peaked at $459.75 per share. However, ABMD stock began to fall when the FDA warned of risks from its Impella RP heart pump. Still, the declines may have stopped as the FDA deemed the Impella RP "safe and effective" back in May. Since August it has rarely risen above $200 per share. Today, it trades at about $188 per share. * 7 Hot Stocks for 2020's Big Trends Thanks to the decline, the forward P/E ratio has fallen to around 37. Profits fell this year. However, double-digit earnings increases should return next year. For the next five years, analysts predict earnings will rise by an average of 24% per year. Like DexCom, it will also benefit as more Americans age into Medicare. As this helps to lead more patients to its heart treatments, ABMD stock should resume its growth pattern. Broadcom (AVGO)Source: Sasima / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $15.34 per share Approximate price today: $315 per share Gain in 2010s: 1,939%The San Jose-based semiconductor company Broadcom (NASDAQ:AVGO) has made itself one of the most significant growth stocks primarily through buying other companies. Formerly known as Avago Technologies, it got its name when it bought another semi company called Broadcom in 2015.Still, AVGO has faced some controversy. Its business with Huawei likely led President Donald Trump's administration to block the Qualcomm (NASDAQ:QCOM) purchase. This came even though the company moved its headquarters back to San Jose after basing its operations in Singapore for a time.However, AVGO stock should grow on future acquisitions. Also, despite its move higher, AVGO stock remains cheap. It currently trades at a forward P/E ratio of about 13.5. Moreover, analysts forecast earnings increases, which have stagnated recently, to return to double-digit levels. They predict almost 17% per-year average growth for the next five years.The ties to China may give some investors pause. However, as China and the U.S. resolve their disputes, AVGO stock should continue its growth well into the 2020s. Jazz Pharmaceuticals (JAZZ)Source: Michael Vi / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $7.88 per share Approximate price today: $150 per share Gain in 2010s: 1,789%Dublin, Ireland-based Jazz Pharmaceuticals (NASDAQ:JAZZ) develops treatments in the areas of sleep as well as hematology and oncology. It derives the majority of its revenue from a drug called Xyrem. However, it has transitioned to newer therapies such as Erwinaze, Defitelio and Vyxeos.Despite its huge run-up, it could again become one of the more prominent growth stocks in the 2020s. For now, it sells at a forward P/E ratio of about 8.7. Also, even with the low multiple, revenue growth remains at double-digit levels. Moreover, Wall Street foresees average earnings increases of 11.1% per year for the next five years.Still, JAZZ stock made the majority of its gains in the first half of the decade. In recent years, it has suffered as Xyrem patents have expired. Also, lagging sales of blood-cancer drug Erwinaze hit JAZZ as it struggles with supply and manufacturing issues. It still trades well below the highs of 2015, when it almost reached $195 per share. * 9 Tantalizing Dividend Stocks for 2020 However, as new drugs replace Xyrem, and as the firm resolves manufacturing issues with Erwinaze, JAZZ stock should finally resume its growth. United Rentals (URI)Source: Casimiro PT / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $9.81 per share Approximate price today: $157 per share Gain in 2010s: 1,520%United Rentals (NYSE:URI) rents heavy equipment to the construction industry. This business model has made URI one of the more successful growth stocks. United Rentals traded in penny-stock status at the height of the financial crisis. This drop helped it to become one of the bigger success stories of the 2010s.But even growth stocks are not immune to challenges. URI stock faced ratings cuts in the fall as some thought recession fears would reduce demand for construction equipment.These fears have made URI stock appear inexpensive. The equity now sells for about 7.8 times next year's earnings. At first, it may look cheap since Wall Street predicts an earnings increase of 18.3% for the year.However, recession fears still appear to influence estimates in future years. Profits are on track to rise by only 4.3% next year and an average of 2.2% per year for the next five years.The economy should determine its immediate future. If we enter a recession, URI will suffer for a time. However, if these fears prove to be overblown, United Rentals could continue its impressive growth well into the 2020s. Align Technology (ALGN)Source: rafapress / Shutterstock.com Split-adjusted closing price on Dec. 31, 2009: $17.82 per share Approximate price today: $275 per share Gain in 2010s: 1,449%Align Technology (NASDAQ:ALGN) produces digital scanners for the dental industry, as well as Invisalign, a product described as "invisible braces." Both patients and investors have taken to Align as its products serve as a replacement for traditional metal braces.ALGN stock rose steadily during the first half of the decade. However, it became one of the better growth stocks as the popularity of Clear Aligner reached a fever pitch.Still, as it approached $400 per share in the fall of 2018, soft earnings guidance led to a sharp selloff. It would go on to lose more than half of its value before recovering to the current level of around $275 per share.Furthermore, even with the drop, the price remains well ahead of fundamentals and growth. The forward P/E ratio now stands at close to 42.5. That seems high for a company with expected profit growth averaging of 18.9%.Moreover, this estimate could come down as competitors such as SmileDirectClub (NASDAQ:SDC), Candid and others begin to take market share. Although ALGN stock has served investors well over the previous decade, the party may end soon as competition forces reductions in both the price and market share of Invisalign.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks That Are Still Worth Buying In 2020 * 7 Strong Stocks to Buy That Won Q3 Earnings * 5 Safety Stocks to Buy Without Trade War Exposure The post 10 Best-Performing Growth Stocks of the 2010s appeared first on InvestorPlace.
Domino's Pizza (NYSE: DPZ), the largest pizza company in the world based on global retail sales, tested its new GPS delivery tracking technology for much of 2019 and the results were clear – everyone loved it! Domino's stores across the U.S. are now adding this new technology and by the end of 2019 roughly a quarter of locations nationwide will have it in place. A significant portion of the remaining stores are expected to have the GPS delivery tracking technology available in 2020.
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the third quarter and hedging or reducing many of […]
Cyber Monday is known for the best deals on technology, merchandise and now … pizza! Domino's Pizza (NYSE: DPZ), the largest pizza company in the world based on global retail sales, is celebrating Cyber Monday with 50-percent-off menu-priced pizzas when customers order online Dec. 2-8.
Domino's (DPZ) gains from digitalization, expansion plans and sales building initiatives. Yet, lowered long-term view and currency headwinds are worrisome.
ANN ARBOR, Mich., Nov. 21, 2019 /PRNewswire/ -- Domino's Pizza (DPZ), the largest pizza company in the world based on global retail sales, is continuing its global growth momentum with the opening of its first store in the Czech Republic. Residents of Brno can now enjoy hot, made-to-order pizza in-store or delivered to their doorstep by Domino's, through a partnership with master franchisee Daufood Czech Republic S.R.O.
Luckin Coffee's stock has been on fire of late. Yahoo Finance speaks with Luckin Coffee CFO Reinout Schakel about the company's plans.
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Domino's Pizza (DPZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quite the week for McDonald's, headlined by a new CEO taking the helm. Here's why one investor is sticking with the stock.
Papa John's reported positive same-store sales growth in North America for the first time in two years during its third quarter.
(Bloomberg) -- When I first met Silicon Valley lawyer David Estrada in 2014, he was an executive at Lyft Inc. who was tussling with New York City regulators. Lyft wanted to allow its drivers to ferry passengers around the city without special licenses. He lost that battle but won the war, helping to persuade dozens of states and countries to change their laws and usher in the age of ride-hailing.It turns out that Estrada’s two years at Lyft were just one part of a 15-year slalom through some of Silicon Valley’s most disruptive companies. He had previously worked at Google X, crafting the first autonomous vehicle legislation in states like California, Florida and Nevada. After Lyft, he moved to Kitty Hawk, Larry Page’s secretive flying car company, and then became the head of legal and policy at Bird Rides Inc., nudging more than 100 U.S. cities and several countries to accept (though not necessarily embrace) street-side electric scooter rentals.Now Estrada is taking on a new role at Nuro Inc., a Mountain View, California-based self-driving car startup founded by two of his former Google colleagues and backed by nearly $1 billion from SoftBank Group Corp.’s Vision Fund. Nuro envisions autonomous cars not only without drivers but without passengers, either. Its goal is to create lightweight vehicles designed for delivering packages, groceries and meals to people’s homes.“My hope is that I can help Nuro achieve the first commercial success with autonomous vehicles, which is really what I set out to do when I started on this path back at Google,” says Estrada, who must first convince regulators and citizens who will likely be skeptical of another wave of Silicon Valley-style disruption in their communities.Nuro completed a pilot program to deliver groceries this year in Scottsdale, Arizona. Next year in Houston, it plans to start delivering food from Kroger Co. and Domino’s Pizza Inc. via an upgraded electric vehicle prototype that can travel up to 25 miles per hour.Estrada will eventually have to navigate a tangle of state and federal authorities. States license individual drivers and oversee their roads and highways, while the National Highway Traffic Safety Administration regulates federal motor vehicle safety standards. The Feds must be convinced to accommodate an entirely new class of self-driving delivery vehicles that theoretically don’t need steering wheels, seats, seat belts, windshield wipers or rear-view mirrors. Nuro’s application for an exemption from safety standards for its vehicles is pending.Estrada plays up the safety of Nuro cars, which are designed to tolerate damage to its cargo in collisions (what’s a few broken eggs in a crash?) while minimizing the impact to other vehicles, pedestrians and pets.He’ll face other concerns as well. In addition to further congesting already clogged city streets, driverless delivery vehicles threaten to put more than 400,000 delivery drivers in the U.S. out of business.Estrada argues that Nuro cars won’t supplant existing delivery people but expand the overall market while creating more jobs inside supermarkets and restaurants and lowering the cost of home delivery services like DoorDash and UberEats. Of course, he’ll have to deliver that message at a time when Amazon.com Inc. is trying to eliminate cashier jobs with its Go store, and chains like McDonald’s Corp. are working on automating functions like the drive-through.Which is why Silicon Valley companies pay him the big bucks. Nuro co-founder and President Dave Ferguson acknowledges the formidable regulatory and PR challenges and says he hopes Estrada can “push us over the finish line.”This article also ran in Bloomberg Technology’s Fully Charged newsletter. Sign up here.And here’s what you need to know in global technology newsUber braces. Many early investors and employees can sell their stock for the first time on Wednesday.FCC inquires. The agency want to know if equipment from Huawei has been installed near sensitive military bases.Match Group dumped. Shares plummeted after the online dating giant disappointed investors with a lackluster financial report.To contact the author of this story: Brad Stone in San Francisco at firstname.lastname@example.orgTo contact the editor responsible for this story: Mark Milian at email@example.comFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
While McDonald’s new CEO, Chris Kempczinski, has said he plans to continue the progress made under his predecessor, headwinds are gathering. Until it’s clear he can navigate the challenges, the stock isn’t worth lovin’.
McDonald's Corp. will pay departing Chief Executive Stephen Easterbrook 26 weeks severance, according to an SEC filing on Monday. Easterbrook made $15.9 million in 2018, including a salary of $1.3 million salary and the rest in stock and option awards and bonuses. McDonald's has set an annual base salary of $1.25 million for Easterbrook's successor, Chris Kempczinski. Easterbrook is eligible for a pro-rated 2019 target incentive plan payment on or about March 1, 2020, but no later than March 15, 2020. And Easterbrook will sign a non-compete agreement effective for two years in which he will not be able to work for a competing company, including Restaurant Brands International Inc.'s Burger King chain, Chick-fil-A, Chipotle Mexican Grill Inc. or Domino's Pizza Inc. . Joe Erlinger, the new president of McDonald's USA, will be paid a base salary of $775,000. McDonald's stock is down 2.5% in Monday trading, but up 7% for the past year. The Dow Jones Industrial Average is up 8.7% for the last 12 months.